NuCana (NASDAQ:NCNA) Trading Down 6.5% – What’s Next?

NuCana plc (NASDAQ:NCNA) was down 6.5% during trading on Thursday . The company traded as low as $1.14 and last traded at $1.15. Approximately 118,431 shares traded hands during mid-day trading, an increase of 6% from the average daily volume of 111,346 shares. The stock had previously closed at $1.23.

NuCana Trading Down 1.7 %

The stock has a market cap of $2.99 million, a P/E ratio of -0.11 and a beta of 0.97. The firm has a 50-day simple moving average of $1.32 and a two-hundred day simple moving average of $2.62.

Institutional Investors Weigh In On NuCana

An institutional investor recently bought a new position in NuCana stock. Glass Jacobson Investment Advisors llc purchased a new position in shares of NuCana plc (NASDAQ:NCNA) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 15,000 shares of the company’s stock, valued at approximately $38,000. Glass Jacobson Investment Advisors llc owned approximately 0.57% of NuCana at the end of the most recent quarter. Institutional investors own 44.00% of the company’s stock.

NuCana Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.